Rewardian, a global leader in employee recognition and engagement technology, today announced a new suite of platform enhancements designed to make recognition effortless, inclusive and data-driven.

According to SNS Insider's forecast, the global Antisense and RNAi Therapeutics market will grow from USD 4.15 billion in 2023 to USD 18.48 billion by 2032, at a compound annual growth rate (CAGR) of ...